Overview
This webinar will give a summary of recently published ESTRO & ASTRO practice guidelines about radiotherapy for lung cancer in the COVID-19 pandemic, whether radiotherapy can or should be adapted, and if so how should this be done. We will address questions about whether radiotherapy can be delayed, fractionation of radiotherapy, multimodality treatment strategies and handling of COVID-19 positive patients. Considering a pandemic scenario characterized by a shortage of radiotherapy resources, we will discuss factors influencing patient prioritization and triage. These questions will be addressed in the format of six clinical cases with curative or palliative treatment for NSCLC and SCLC.
Format: The program will have the following format: Sequential discussion of 6 cases presented in ASTRO-ESTRO practice guideline, with Q & A after each case.
Key Files
The target audience for this program includes radiation oncologists and clinical oncologists practicing lung cancer radiotherapy, as well as all disciplines with an interest in lung cancer radiotherapy.
Prof Corinne Faivre-Finn FRCR, MD, PhD
Professor of Thoracic Radiation Oncology
Honorary Consultant Clinical Oncologist
The Christie NHS Foundation Trust
Matthias Guckenberger, MD
Department of Radiation Oncology
University Hospital Zurich (UHZ)
University of Zurich
David Palma, MD, MSc, PhD, FRPC
Division of Radiation Oncology
Western University
London, Canada
Disclosure: All faculty and planners have reported that they have no relevant financial relationships to disclose.
The target audience for this program includes radiation oncologists and clinical oncologists practicing lung cancer radiotherapy, as well as all disciplines with an interest in lung cancer radiotherapy.
Prof Corinne Faivre-Finn FRCR, MD, PhD
Professor of Thoracic Radiation Oncology
Honorary Consultant Clinical Oncologist
The Christie NHS Foundation Trust
Matthias Guckenberger, MD
Department of Radiation Oncology
University Hospital Zurich (UHZ)
University of Zurich
David Palma, MD, MSc, PhD, FRPC
Division of Radiation Oncology
Western University
London, Canada
Disclosure: All faculty and planners have reported that they have no relevant financial relationships to disclose.
Share
Related Content
